Optimi Health is trading at $2.78, with a -8.55% change; no clear company-specific announcement or credible report explains the October 28 decline. - The latest identified company updates—a new Australian distribution subsidiary announced October 26 and MDMA production completed October 20—predate the move and do not establish a cause. - Biotech was reported higher, while major indices were nearly flat to modestly positive; neither provides a clear explanation for the drop.